Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 14,860Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Global Blood Therapeutics

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

VOXELOTOR

Brand Name : OXBRYTA

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date : 2019-11-25

Application Number : 213137

Regulatory Info : RX

Registration Country : USA

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

VOXELOTOR

Brand Name : OXBRYTA

Dosage Form : TABLET;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2022-10-14

Application Number : 213137

Regulatory Info : RX

Registration Country : USA

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

VOXELOTOR

Brand Name : OXBRYTA

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 300MG

Packaging :

Approval Date : 2021-12-17

Application Number : 216157

Regulatory Info : RX

Registration Country : USA

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

VOXELOTOR

Brand Name : OXBRYTA

Dosage Form : TABLET;ORAL

Dosage Strength : 500MG

Packaging :

Approval Date :

Application Number : 216157

Regulatory Info :

Registration Country : USA

blank